Literature DB >> 27546843

Colorectal Cancer: Genetics is Changing Everything.

Joshua C Obuch1, Dennis J Ahnen2.   

Abstract

Cancer is fundamentally a genetic disease caused by mutational or epigenetic alterations in DNA. There has been a remarkable expansion of the molecular understanding of colonic carcinogenesis in the last 30 years and that understanding is changing many aspects of colorectal cancer care. It is becoming increasingly clear that there are genetic subsets of colorectal cancer that have different risk factors, prognosis, and response to treatment. This article provides a general update on colorectal cancer and highlights the ways that genetics is changing clinical care.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; Genetics; Prevention; Review; Screening; Survivorship; Treatments

Mesh:

Substances:

Year:  2016        PMID: 27546843     DOI: 10.1016/j.gtc.2016.04.005

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  17 in total

Review 1.  K-ras Mutations as the Earliest Driving Force in a Subset of Colorectal Carcinomas.

Authors:  Nikolaos Margetis; Myrsini Kouloukoussa; Kyriaki Pavlou; Spyridon Vrakas; Theodoros Mariolis-Sapsakos
Journal:  In Vivo       Date:  2017 Jul-Aug       Impact factor: 2.155

2.  Age-dependent prognostic value of KRAS mutation in metastatic colorectal cancer.

Authors:  Muhammet Ozer; Suleyman Yasin Goksu; Nina Niu Sanford; Chul Ahn; Muhammad Shaalan Beg; Syed Mohammad Ali Kazmi
Journal:  Future Oncol       Date:  2021-11-11       Impact factor: 3.674

3.  Overexpression of Long Noncoding RNA LBX2-AS1 Promotes the Proliferation of Colorectal Cancer.

Authors:  Qing Li; Hui Xie; Zefu Jin; Jing Huang; Shuting Wang; Zijian Zhang
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

4.  A novel lncRNA, LL22NC03-N64E9.1, represses KLF2 transcription through binding with EZH2 in colorectal cancer.

Authors:  Yifan Lian; Changsheng Yan; Jie Ding; Rui Xia; Zhonghua Ma; Bingqing Hui; Hao Ji; Jing Zhou; Keming Wang
Journal:  Oncotarget       Date:  2017-07-31

5.  miR-503-5p confers drug resistance by targeting PUMA in colorectal carcinoma.

Authors:  Ke Xu; Guo Chen; Yanyan Qiu; Zeting Yuan; Hongchang Li; Xia Yuan; Jian Sun; Jianhua Xu; Xin Liang; Peihao Yin
Journal:  Oncotarget       Date:  2017-03-28

6.  CircRNA SMARCC1 Sponges MiR-140-3p to Regulate Cell Progression in Colorectal Cancer.

Authors:  Miao-Sheng Chen; Cui-Hong Lin; Ling-Yan Huang; Xiao-Ming Qiu
Journal:  Cancer Manag Res       Date:  2020-06-23       Impact factor: 3.989

7.  MicroRNA-663b enhances migration and invasion by targeting adenomatous polyposis coli 2 in colorectal carcinoma cells.

Authors:  Fenqiang Xiao; Wangbin Chen; Chao Yu; Gang Zhao
Journal:  Oncol Lett       Date:  2020-03-27       Impact factor: 2.967

8.  CASP8 rs3834129 (-652 6N insertion/deletion) Polymorphism and Colorectal Cancer Susceptibility: An Updated Meta-Analysis.

Authors:  Yin Ying; Jin Xu; YaJun Qi; Meiling Zhang; Yue Yang
Journal:  J Cancer       Date:  2018-10-18       Impact factor: 4.207

9.  Long non-coding RNA SNHG16 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer via sponging miR-200a-3p.

Authors:  Yanling Li; Ying Lu; Yanglong Chen
Journal:  Biosci Rep       Date:  2019-05-17       Impact factor: 3.840

10.  Synthesis, Anti-Proliferative Activity Evaluation and 3D-QSAR Study of Naphthoquinone Derivatives as Potential Anti-Colorectal Cancer Agents.

Authors:  Julio Acuña; Jhoan Piermattey; Daneiva Caro; Sven Bannwitz; Luis Barrios; Jairo López; Yanet Ocampo; Ricardo Vivas-Reyes; Fabio Aristizábal; Ricardo Gaitán; Klaus Müller; Luis Franco
Journal:  Molecules       Date:  2018-01-17       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.